SENTRY™ – Placental-Derived Allograft

Placental Tissue & Safety

Sentry™ is a placental-derived allograft composed of a single layer of amniotic membrane. Developed using a proprietary tissue processing technique, it is intended as a barrier or wound cover for acute and chronic wounds, especially shallow-to-moderate wound beds.

Key points:

  • Derived from amnion membrane, the internal (fetal-facing) layer of the placenta.
  • The amnion is thin, compact, and highly elastic, allowing it to conform closely to wounds while offering protection.
  • Composed of collagen fibers (Types I, III, IV, V), laminin, fibronectin, proteoglycans, and hyaluronic acid.

Tissue sourcing & safety:

  • Tissues are donated by fully consented mothers undergoing full-term C-sections.
  • All donors are screened per FDA and American Association of Tissue Banks standards.
  • Undergoes a validated terminal sterilization process.
  • Tissue recovery is done through FDA-regulated and accredited organizations.

Product Summary

  • Minimally manipulated and dehydrated amniotic membrane.
  • Retains the natural structural and functional properties of the tissue.
  • Sterilized to a 10⁻⁶ SAL.
  • Classified as a 361 HCT/P.
  • Intended as a biologic wound covering or skin substitute for cutaneous wounds.
  • Use by licensed healthcare professionals in office, outpatient, or inpatient settings.

References: